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DCs  and  macrophages  are  highly  hetero­
geneous cells (Vremec and Shortman, 1997; 
Shortman and Liu, 2002; Gordon and Taylor, 
2005; Ziegler­Heitbrock et al., 2010). Their 
myriad subtypes exhibit a blend of shared and 
unique functions that tailor their abilities to 
regulate innate and adaptive immune responses. 
In mouse LNs, conventional DCs include the 
CD8+ and CD11b+ subgroups, the latter sub­
divided  based  on  CD4  expression  (Vremec   
et al., 2000; Allan et al., 2003; Belz et al., 2004; 
Hildner et al., 2008). Recent DC immigrants 
populating skin draining LNs (DLNs) include 
Langerhans cells and CD8 CD103+ dermal 
DCs  (Randolph  et  al.,  2008;  Bedoui  et  al., 
2009). An additional subset, plasmacytoid DCs 
(pDCs) are copious producers of type I IFNs 
(Swiecki and Colonna, 2010). Microbial infec­
tions  typically  increase  DC  numbers  in  the 
DLN, and induce the differentiation of inflam­
matory DCs (Serbina et al., 2003).
Macrophage subtypes are less clearly estab­
lished than DC subtypes, but can be delineated 
based  on  anatomical  location  (e.g.,  marginal 
zone splenic macrophages) or expression of cell 
surface receptors (e.g., CD169, mannose re­
ceptor, MARCO, and dectin­1; Taylor et al., 
2005). Within the LN, both subcapsular sinus 
(SCS)  and  medullary  macrophages  express   
sialoadhesin  (CD169),  with  the  latter  distin­
guished by coexpression of F4/80 (Phan et al., 
2009). The inflammatory milieu heavily influ­
ences the differentiation state of macrophages 
(Serbina et al., 2008; Liu et al., 2009).
LN  macrophages  have  recently  been  the 
subject of intense investigation because of their 
rapid and efficient uptake of lymph­borne par­
ticles deposited into the LN SCS. After antigen 
capture, SCS macrophages can relay antigen to 
follicular B cells (Carrasco and Batista, 2007; 
Junt et al., 2007; Phan et al., 2007), a step that 
promotes the affinity maturation of antibodies 
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Naive antiviral CD8+ T cells are activated in the draining LN (DLN) by dendritic cells 
(DCs) presenting viral antigens. However, many viruses infect LN macrophages, which 
participate in initiation of innate immunity and B cell activation. To better understand 
how and why T cells select infected DCs rather than macrophages, we performed intravi-
tal microscopy and ex vivo analyses after infecting mice with vaccinia virus (V V),  
a large DNA virus that infects both LN macrophages and DCs. Although CD8+ T cells 
interact with both infected macrophages and DCs in the LN peripheral interfollicular 
region (PIR), DCs generate more frequent and stable interactions with T cells. V V infec-
tion induces rapid release of CCR5-binding chemokines in the LN, and administration  
of chemokine-neutralizing antibodies diminishes T cell activation by increasing T cell 
localization to macrophages in the macrophage-rich region (MRR) at the expense of PIR 
DCs. Similarly, DC ablation increases both T cell localization to the MRR and the duration 
of T cell–macrophage contacts, resulting in suboptimal T cell activation. Thus, virus-
induced chemokines in DLNs enable antiviral CD8+ T cells to distinguish DCs from macro-
phages to optimize T cell priming.
This article is distributed under the terms of an Attribution–Noncommercial–Share 
Alike–No Mirror Sites license for the first six months after the publication date 
(see http://www.rupress.org/terms). After six months it is available under a Cre-
ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported 
license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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To better understand the priming of antiviral CD8+  
T cells in vivo, we have combined intravital multiphoton 
microscopy  (MPM)  with  other  approaches  to  dissect 
mechanisms controlling T cell activation during viral in­
fection. We show that CD8+ T cells interact with both vi­
rally infected macrophages and DCs in vivo in the DLN. 
Macrophage  interactions,  however,  cannot  fully  prime   
antiviral CD8+ T cells. To optimize priming, CD8+ T cells 
use chemokines to guide them to DCs in vivo, and neu­
tralizing these chemokines diminishes the antiviral CD8+ 
T cell response.
RESULTS
Definition of a macrophage-rich region (MRR)  
of the inguinal LN
Visualizing macrophages and DCs in vivo using MPM ne­
cessitates the unambiguous, simultaneous fluorescent detec­
tion  of  both  cell  populations.  Although  CD11c­eYFP 
reporter mice allow DC analysis via MPM (Lindquist et al., 
2004), no red fluorescent counterpart exists for macrophages. 
Gretz et al. (2000) showed that s.c. injected dextran ≥70 kD 
was initially excluded from cortical areas of the LN but flowed 
into the subcapsular and medullary sinuses, where it accumu­
lated in unidentified 
phagocytic cells. Sub­
sequently, Carrasco 
and  Batista  (2007) 
identified this region   
(Abs; Phan et al., 2009). As SCS macrophages express lower 
levels of several proteases involved in proteolytic degradation 
of phagocytosed antigen, Phan et al. (2007) suggested that 
their function may be to maintain a reservoir of antigen for 
relay to LN B cells. However, many SCS macrophages are 
not located above B cell follicles, but rather above the T cell 
zone in the peripheral interfollicular regions (PIRs) of the 
node (Hickman et al., 2008), suggesting their participation in 
T cell responses.
As with other particulate antigens, virions trafficking to the 
LNs via the lymphatics are internalized by SCS macrophages 
(Norbury et al., 2002; Junt et al., 2007; Hickman et al., 2008; 
Iannacone et al., 2010). Both vaccinia virus (VV) and vesicular 
stomatitis virus readily infect nodal macrophages, which ac­
count for up to 85% of virus­infected LN cells within a few 
hours of infection (Norbury et al., 2002; Hickman et al., 2008). 
Functionally, SCS macrophages limit vesicular stomatitis vire­
mia and dissemination (Junt et al., 2007), and are a critical 
source of type I IFNs (Iannacone et al., 2010). Although macro­
phages express the appropriate machinery for T cell activation, 
numerous studies have shown through in vivo ablation or   
ex vivo isolation that DCs prime CD8+ T cells after viral 
infection (Allan et al., 2003; Probst et al., 2005; Ciavarra 
et al., 2006; Kassim et al., 2006). It is currently unknown 
whether CD8+ T cells interact with infected LN macrophages. 
Additionally, because infected macrophages and DCs are inti­
mately intermingled in the PIRs, it is unclear how T cells se­
lect DCs for priming over the more numerous macrophages.
Figure 1.  Histological characterization  
of the MRR of the LN. (A and B) Frozen LN 
sections from WT mice given 70-kD tetra-
methylrhodamine-labeled dextran (red) 30 
min before excision. (A) ER-TR7 staining (grey) 
identifies the following nodal regions: MRR, 
macrophage-rich region; PIR, peripheral inter-
follicular region; CA, capsule; SCS, subcapsu-
lar sinus; CR, cortical ridge; B, B cell follicle;  
T, T cell zone. (B) Mosaic-tiled confocal images 
of whole LNs stained with different Abs (grey, 
left images), and higher magnification  
images of staining of the MRR (right images).  
(C) Number of dextran+ cells per node per cell 
type as determined by node dissociation fol-
lowed by flow cytometry. Cells were gated on 
FITC-dextran positivity and divided into 
CD11b+ DCs (CD11c+CD11b+ cells), CD11b 
DCs (CD11c+CD11b cells), and macrophages 
(CD11cCD11b+ cells). Macrophages were 
further gated on F4/80 to identify medullary 
macrophages (F4/80+). Dextran+ cells belong-
ing to each population were quantified  
using flow cytometric percentages and  
total node counts. (D) MPM images  
from CD11c-eYFP mice given dextran. Bottom 
panels show higher magnification. CD11c+ 
cells (green), collagen (second harmonic  
generation, blue), dextran+ cells (red).  
(E) High-magnification confocal image of 
whole-mounted CD11c-eYFP LNs after dextran 
administration. CD11c+ cells (green), dextran+ 
cells (red). Scale bars are shown in micrometers.  
We made similar observations in at least three 
additional experiments per image.JEM Vol. 208, No. 12 
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CD8+ T cells interact with V V-infected macrophages  
and DCs in vivo
Previously, we showed that CD8+ T cells in virus­DLNs 
form  intimate,  enduring  antigen­specific  interactions  with 
virus­infected  cells,  leading  to  T  cell  activation  (Norbury   
et al., 2002; Hickman et al., 2008). Notably, interactions oc­
curred in a relatively small subregion of the LN, the PIR, and 
as  a  macrophage­rich  area. Therefore,  to  visualize  macro­
phages, we injected mice s.c. with 70 kD tetramethylrhoda­
mine dextran (red fluorescent) and examined excised nodes 
at 30–45 min after injection by immunohistochemistry and 
flow cytometry (Fig. 1).
Dextran+ cells were clearly visible in frozen sections at the 
periphery of the LN, both in the SC and medullary sinuses, 
as well as in the interfollicular channels identified via staining 
of the LN stroma with ER­TR7 (Fig. 1 A). Dextran+ cells 
composed a distinct area of the cortical ridge (CR) region of 
the LN (Katakai et al., 2004) between the T cell zone and   
B cell follicles. Additional staining clearly identified the dex­
tran+ cells as SCS and medullary macrophages (Fig. 1, B and C), 
indicated by expression of CD11b and CD169 (SCS mac­
rophages)  and  F4/80  on  medullary  macrophages  (Phan   
et al., 2009). Although the overwhelming majority of con­
ventional (CD11c+) DCs do not endocytose dextran (visual­
ized by MPM; Fig. 1, D and E), we detected a minor 
population of dextran+ CD11b+ CD11c+ DCs using flow   
cytometry (Fig. 1 C). Conventional DCs are positioned on 
either side of the dextran+ cells in the CR, clearly distinct 
from macrophages using MPM (Fig. 1, D and E; and Videos 
1 and 2). This region of dense dextran+ macrophages over­
laps but is not identical to either the PIR or CR and repre­
sents the MRR.
Together, these data support the use of dextran endocyto­
sis for the in vivo labeling of LN macrophages in the sinuses 
and MRR.
SCS and medullary macrophages become infected  
by lymph-borne virus
We previously reported that SCS macrophages are the pre­
dominant infected cell in the DLN after s.c. VV injection 
(Norbury et al., 2002; Hickman et al., 2008). Now other 
lymph­borne viruses have been shown to infect or accumu­
late in SCS macrophages (Hsu et al., 2009; Gonzalez et al., 
2010). Although these studies relied exclusively on CD169 to 
identify  SCS  macrophages,  it  is  now  clear  that  medullary 
macrophages also express this marker (Phan et al., 2009).
Thus, we reexamined LNs (Fig. 2) using CD169 and 
F4/80 in flow cytometry to distinguish macrophage popula­
tions 8–10 h after infecting mice s.c. with a recombinant   
VV (rVV) expressing a red fluorescent protein (VV­NP­ 
S­mCherry; Table I). This revealed that >90% of VV­ 
infected  LN  cells  were  CD169+  or  CD11chigh/intermediate  
(Fig. 2, A–C). Approximately 15% of infected cells were 
DCs, with the remainder being CD169high/intermediate. As ex­
pected, almost all of the CD169+ cells were also CD11b+, 
with 56% being F4/80dim SCS macrophages (Fig. 2 B, far 
right) and 38% being F4/80+ medullary macrophages.
To  confirm  this  finding,  we  performed  whole­mount 
F4/80 staining of nodes removed 10 h post infection (hpi; 
Fig.  2  D).  We  detected  a  substantial  number  of  F4/80+,   
dextran+ VV­infected cells in the LN. Thus, both medullary 
macrophages and SCS macrophages are robustly infected by 
virus draining to the LN.
Figure 2.  LN SCS and medullary macrophages are infected by V V. 
(A) Flow cytometric analysis of single-cell LN suspensions from saline-
injected mice. CD169+CD11clo macrophages can be further divided into 
CD11b+F4/80 SCS or CD11b+F4/80+ medullary macrophages. (B) LNs 
from V V-infected mice 10 hpi. Cells were gated based on expression of a 
vaccinia-expressed fluorescent protein, into DCs and CD169+ macro-
phages, and finally on F4/80+ or F4/80 cells. (C) Numbers of vaccinia-
infected cells in different nodal populations. Circles indicate individual 
LNs, and bars show mean. (D) Whole-mount confocal images of LNs 10 
hpi, with V V-NP-S-mCherry (red). Macrophages, green (FITC- 
labeled dextran); F4/80, grey. Scale bars are shown in micrometers.  
Data are representative of three experiments.2514 Chemokine-dependent APC choice | Hickman et al.
viral gene products and DCs. By generating rVVs that express 
an  antigenic  protein  genetically  fused  to  mCherry  (NP­S­
mCherry) we could simultaneously image viral antigens, eYFP­
expressing DCs, and adoptively transferred, fluorescently 
labeled, antigen­specific CD8+ T cells (OT­I cells, recognizing 
Kb­SIINFEKL; Clarke et al., 2000).
At 10 hpi, we imaged excised inguinal 
LNs via confocal microscopy (Fig. 3 A), or 
inguinal LNs in living animals using MPM 
(Fig. 3 B). In uninfected nodes or nodes 
infected with a control rVV lacking SIIN­
FEKL, few OT­I cells are present in the 
PIR  (Video  3).  After  VV  infection  with   
a SIINFEKL­containing virus (VV­NP­S­
mCherry  [red]),  we  commonly  observed 
OT­I cells contacting infected DCs (Fig. 3, 
A and B; and Video 4). We also identified 
OT­I  cells  interacting  with  likely  unin­
fected DCs (we cannot rigorously exclude 
expression  of  fluorescent  protein  below   
detection limits) and infected eYFP cells 
identified as macrophages in other analyses 
antigen was required for T cell accumulation in the PIR and 
for sustained DC–T cell interactions (Hickman et al., 2008). 
However,  we  were  technically  unable  to  simultaneously 
identify virus­infected cells and DCs by MPM because of 
spectral overlap of the fluorescent proteins used to visualize 
Table I.  Viruses used in this study
Abbreviation Full name Antigen Fluorescent 
protein
Advantage
V V-ova V V-ovalbumin full-length ovalbumin (secreted) none standard construct
V V-SIINFEKL V V-SIINFEKL MSIINFEKL none not cross-primed
V V-NP-S-eGFP V V-Influenza A virus nucleoprotein-
SIINFEKL-enhanced green fluorescent 
protein
SIINFEKL as a fusion protein eGFP standard construct
V V-NP-S-mCherry V V-Influenza A virus nucleoprotein-
SIINFEKL-mCherry fluorescent protein
SIINFEKL as a fusion protein mCherry standard construct; red 
fluorescence
V V-Venus-ub-S V V-Venus enhanced yellow fluorescent 
protein-ubiquitin-SIINFEKL
SIINFEKL as a minigene liberated via 
ubiquitin hydrolases
Venus eYFP brightest fluorophore
V V-Venus-ub-NP V V-Venus enhanced yellow fluorescent 
protein-ubiquitin-ASNENMETM
none for OT-I cells Venus eYFP control fluorescent virus
V V--gal V V--galactosidase none; backbone for recombinant V Vs none control nonfluorescent virus
Figure 3.  CD8+ T cells interact with LN DCs and 
macrophages after viral infection. (A) LNs from 
CD11c-eYFP mouse (green DCs) excised 10 hpi with 
V V-NP-S-mCherry (red) were examined as whole 
mounts by confocal microscopy. OT-I cells were la-
beled with Cell Tracker Blue before transfer. (B) MPM 
images of the inguinal LN, as in A. (C) MPM images 
from the top 30 µm of the inguinal node of CD11c-
eYFP mice given fluorescent-dextran (red) to label 
macrophages and OT-I cells (blue). Uninfected nodes 
(left) 10 hpi with nonfluorescent backbone virus  
(V V--gal; control, middle left) or V V-Ova (middle 
right). (right) A schematic of T cell localization in 
relation to macrophages after V V infection. DCs 
(green), MRR (red), OT-I cells (blue; right). Scale bars 
are shown in micrometers. We made similar observa-
tions in two additional experiments.JEM Vol. 208, No. 12 
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generation of bone­marrow chimeras, our short­term assays 
were performed simply with transgenic animals. Thus, to mea­
sure T cell activation in the absence of DCs, we adoptively 
transferred OT­I cells (because of the potential effects of DTx 
on autologous T cells in DTR mice, which can express CD11c 
[and DTR] upon activation; Jung et al., 2002), administered 
DTx, and examined OT­I cell proliferation in rVV­infected 
LNs (Fig. 4, A and E). DTx treatment greatly reduced (but 
did not eliminate) OT­I cell proliferation in response to VV­ 
encoded antigen. We next analyzed several common T cell 
activation markers (Fig. 4, C–E). Macrophage­activated T cells 
failed to normally up­regulate CD25 or down­regulate CD62L 
(Fig. 4, C and D). Although CD69 was induced in OT­I cells, 
it was dysregulated in comparison to cells activated in the pres­
ence of DCs (at 36 h there was less down­regulation compared 
with WT; Fig. 4 E), and CD69 was not up­regulated at all   
under the same circumstances in different TCR transgenic   
T cells (unpublished data). Reducing the number of OT­I cells 
transferred failed to restore their normal activation phenotype 
(unpublished data), indicating that this phenomenon is unlikely 
to be an artifact of using a high precursor frequency of TCR­
transgenic cells (Badovinac et al., 2007).
Such  macrophage  activated­CD8+  T  cells  demonstrated 
functional defects as well (Fig. 4, F–I). OT­I cells were transferred 
into CD11c­DTR­eGFP mice that received DTx 12 h. before 
infection with VV­Ova (Table I). In untreated mice, 90% of 
(Video 4). We routinely identified multiple examples of 
each interaction occurring in individual LNs (Fig. 3 B).
We next labeled macrophages in CD11c­eYFP mice via 
s.c. dextran injection. Few OT­I cells were located at the pe­
riphery of the uninfected LNs, or in nodes infected with con­
trol virus (Fig. 3 C left and center panels and Video 3). In 
contrast, infection with VV expressing cognate antigen in­
duced OT­I cells to localize to the PIR (Fig. 3 C, Video 3, 
and Video 5). Most (but not all) OT­I cells were excluded 
from the MRR (Fig. 3 C, schematic, far right).
Collectively, these data indicate that although most CD8+ 
T cells interact with infected and uninfected DCs, they can 
and do interact with VV­infected PIR macrophages under 
normal circumstances.
V V-infected macrophages stimulate T cell division  
but not activation
What happens when CD8+ T cells interact exclusively with 
infected macrophages? We forced T cells to use infected   
macrophages as APCs, using CD11c­diphtheria toxin (DTx)   
receptor (DTR)­eGFP mice (Jung et al., 2002) that were pre­
viously used for ex vivo analyses of immune responses to other 
viruses (Ciavarra et al., 2005; Probst et al., 2005; Kassim et al., 
2006). In this system, administration of DTx results in DC 
ablation in vivo, leaving macrophages as the only infected cell 
type in the DLNs. Although long­term DC depletion requires 
Figure 4.  CD8+ T cell interactions with 
macrophages are largely nonproductive. 
(A) LN OT-I cells dividing in response to s.c. 
delivery of V V-NP-S-eGFP. 5 × 106 OT-I 
CFSE-labeled OT-I cells were transferred into 
CD11c-DTR-eGFP mice. 12 h later, mice were 
treated with DTx or PBS (untreated). After an 
additional 12 h, mice were infected with  
V V (untreated and DTx) or left uninfected  
(naive). Cells were analyzed at 48 hpi for divi-
sion. Far right panel shows overlays. Un-
treated mice, black lines; DTx-treated mice, 
red lines; uninfected DTx-treated, filled grey 
lines. Numbers = OT-I cells recovered.  
(B) Graph showing percentage of dividing OT-I 
cells. Dots represent individual nodes.  
(C–E) Activation marker profile of T cells. Histo-
grams were only gated on dividing cells. 
Untreated mice, black lines; DTx-treated 
mice, red lines; uninfected DTx-treated, filled 
grey lines. Numbers in top right corner indi-
cate time after infection. (F) IFN- produc-
tion (y axes) versus division (indicated by 
CFSE dilution; x axes) at 2 days after infec-
tion with V V-Ova. (G) Graphical representa-
tion of data shown in F. Dots represent 
individual nodes. (H) 2 × 106 OT-I cells were 
transferred into CD11c-DTR-eGFP mice (ex-
pressing CD45.2) that were treated with DTx 
(middle) or PBS (right) before intradermal infection with V V-SIINFEKL in the ear pinnae. 4 days after infection, ears were removed and analyzed for 
the percentage of OT-I cells present (CD8+CD45.1+ cells). (I) Graphical representation of data in H. All experiments were performed at least three times 
with three to six animals/group yielding similar results.2516 Chemokine-dependent APC choice | Hickman et al.
which is decreased viral infection/antigen presentation in the 
DC­depleted LNs. To analyze this, we infected DTX­treated 
CD11c­DTR­eGFP mice or nontreated WT mice with   
VV­NP­S­eGFP  and  visualized  infected  cells  by  MPM   
(Fig. 5 A). Numerous VV­infected cells were present just 
beneath the SCS of the DLN in untreated or DTx­treated   
animals  (Fig.  5 A).  Most  infected  cells  were  macrophages 
(Video 6), as indicated by in vivo endocytosis of fluorescent 
dextran administered s.c., and confirmed by CD11b+ staining 
(Fig. 5 B) or F4/80 staining (Fig. 5 C) of whole­mount LN 
sections. Using flow cytometry, we found that almost all of 
the infected LN cells recovered from DTx­treated mice (10­
fold fewer than recovered from untreated mice) were CD11b+, 
CD169+, F4/80+ medullary macrophages (Fig. 5 D).
To examine the ability of DTx­resistant macrophages to 
present rVV antigens, we infected mice with a rVV express­
ing  a  highly  fluorescent  fusion  protein  (Venus­ubiquitin­ 
SIINFEKL) that generates large amounts of cytosolic SIINFEKL 
because of co­translational liberation of SIINFEKL by cellu­
lar ubiquitin hydrolases (or an irrelevant control virus ex­
pressing Venus­eYFP but lacking SIINFEKL; Table I; Fruci   
et al., 2003; Lev et al., 2010). We removed DLN 6 hpi and mea­
sured expression of Kb­SIINFEKL on dissociated cells by flow 
cytometry  using  a  fluorescent  conjugate  of  the TCR­like   
OT­I cells produced IFN­ at 2 d after infection when restim­
ulated with SIINFEKL peptide (compared with <0.2% when 
stimulated with an irrelevant peptide; Fig. 4, F and G). In 
CD11c­depleted mice, however, <8% of cells produced IFN­ 
in response to SIINFEKL peptide, and even cells that had di­
vided 5 times synthesized less IFN­ on average. DTx treatment 
did not modify IFN­ production in non–DTR transgenic 
(C57BL/6) mice (unpublished data).
A hallmark of effector CD8+ cells is their ability to traffic 
from LNs to peripheral infection sites. We transferred OT­I 
cells  into  CD11c­DTR­eGFP  mice  treated  with  DTx  or   
untreated­mice and infected intradermally in the ear with 
VV­SIINFEKL. 4 d later, ears were removed and examined 
for the presence of OT­I cells (Fig. 4, H and I). Remarkably, 
macrophage­primed  OT­I  cells  from  DTx­treated  mice 
completely failed to traffic to the infection site.
Together,  these  data  indicate  that  macrophage­primed 
CD8+ T cells exhibit diminished proliferation, altered activa­
tion, and greatly reduced functionality, pointing to the im­
portance of DC­mediated activation in this system.
DC-ablated LNs still present viral antigen
Several possible explanations exist for the altered priming   
in DTx­treated CD11c­DTR­eGFP mice, the simplest of 
Figure 5.  Infected macrophages present antigen in DC-ablated mice. (A) V V-NP-S-eGFP–infected cells (green) just under the collagenous capsule of 
the node (second harmonic generation (blue)). Numbers of infected cells in nonablated (untreated) and DC-ablated (DTx-treated) mice (right). (B) Confocal 
microscopy of a frozen section of a DC-ablated LN 10 hpi with V V-NP-S-mCherry (red) showing only the red and green channels (left), only the red and 
grey channels (middle), or all channels (right). FITC-dextran (green) and anti-CD11b staining (white) identify macrophages. (C) Same as shown in B, except 
staining with F4/80 (grey) to identify medullary macrophages. (D) Numbers of infected cells of each cell type in the node. Cells were gated into CD11c+CD169 
(DCs) or CD11cdimCD169+ (CD169+ macrophages), then CD169+ macrophages were further gated based on F4/80 expression. Background (blue) is caused by 
low cell recovery and macrophage autofluorescence. (E) Flow cytometric analysis of LN single-cell suspensions from untreated or DTx-treated animals 6 hpi with 
V V-venus-ubiquitin-SIINFEKL. Cells were stained with 25D-1.16 recognizing Kb-SIINFEKL complexes. Histograms are gated on infected cells (Venus eYFP+). 
Infected with virus lacking SIINFEKL (grey shaded histograms), infected without 25D-1.16 stain (black lines), infected untreated mice (blue lines), and in-
fected DTx-treated mice (red lines). Scale bars are shown in micrometers. Results are shown from one experiment of two (A–C) or four (D and E).JEM Vol. 208, No. 12 
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infection, forming stable contacts with virus­infected cells in 
the presence of cognate antigen (Hickman et al., 2008). No­
tably, in the absence of specific antigen, CD8+ T cells in the 
periphery move at reduced speeds compared with those in 
the deeper T cell zone, yet fail to form immotile, stable con­
tacts with non–antigen­expressing APCs. To analyze T cell 
behavior in DC­ablated mice, we transferred 107 OT­I cells 
into CD11c­DTR­eGFP mice, treated mice with DTx, in­
fected with VV­SIINFEKL 12 h later, and imaged the DLN 
6 hpi after injection of fluorescent dextran to identify macro­
phages (Fig. 6, A and B and Video 6). Remarkably, in DTx­
treated  mice,  82%  of  OT­I  cells  localized  to  the  MRR 
compared with 18% in untreated mice. Complete T cell acti­
vation requires stable prolonged contact between T cells and 
APCs (Mempel et al., 2004; Henrickson 
et al., 2008). MPM revealed that most 
OT­I cells in the MRR of DTx­treated 
mice were relatively immotile throughout 
antibody 25D­1.16 (Fig. 5 E). Cells from both untreated and 
DTx­treated mice were specifically stained with 25­D1.16, 
demonstrating that APCs in DTx­treated mice are able to 
generate class I peptide complexes from endogenous antigens, 
although at lower levels than in untreated mice.
Collectively, these data demonstrate that medullary macro­
phages are infected in DTX­treated mice and infected cells 
still  robustly  present  antigen  in  the  node,  albeit  at  lower 
numbers and antigen levels than in untreated mice.
CD8+ T cells establish stable interactions with infected 
macrophages in the absence of DCs
How do CD8+ T cells behave in the absence of DCs? In DC­
competent mice, T cells rapidly transit to the periphery after 
Figure 6.  CD8+ T cells stably interact with 
V V-infected cells in DC-ablated mice.  
(A) MPM images of untreated or DTx-treated 
CD11c-DTR-eGFP animals that were given 1.0 × 107 
Cell Tracker Red (red) labeled OT-I cells before  
DC depletion. Images acquired 6 hpi with V V-
SIINFEKL (nonfluorescent). The macrophage rich-
region (MRR) was identified by in vivo uptake of 
FITC-dextran (green). (B) Percentage of OT-I cells 
per 63X field (238 × 238 × 85 µm) located in the 
MRR in untreated or DTx-treated mice. Results 
were analyzed with an unpaired t test. (C) Time-
lapse MPM images of OT-I cells (red) in the LN of 
untreated (top panels) or DC-ablated (bottom 
panels) mice 6–10 hpi with V V-NP-S-eGFP 
(green). White circles indicate stable contacts. For 
untreated mice, 106 OT-I cells were transferred; 
for DTx-treated, 107 (it was necessary to transfer 
more OT-I cells into DTx-treated mice than un-
treated mice due to decreased homing to the LN 
following DTx-mediated ablation). (D) Calculation 
of contact times between OT-I cells and V V- 
infected cells over the course of a 30 min imag-
ing session. (E) Plot of OT-I cells’ movement (step 
size) between individual frames of a 30 min 
movie in untreated vs. DC-ablated mice. We clas-
sified movement under 0.5 µm between frames 
as a pause step. (F) Calculation of the percentage 
of T cells arresting in each condition. (G) Color-
mapped plot of T cell tracks during a 30-min 
movie. Each box on grid is 20 × 20 µm. Increasing 
track speed is colored from purple to red (bottom 
bar). (H) Calculation of average OT-I cell speed in 
untreated or DTX-treated mice. Results are shown 
from one experiment of three to six with similar 
results. No differences between untreated and 
DTx-treated mice were statistically significant 
according to unpaired Student’s t tests. Time  
is shown in minutes. Scale bars are shown  
in micrometers.2518 Chemokine-dependent APC choice | Hickman et al.
the protein levels of several chemokines on excised nodes. 
VV infection increased levels of 5 chemokines examined at   
6 hpi, with all except CCL3 being significantly greater at   
12 hpi (Fig. 8). The greatest increases were seen with CCL2 
and CCL4. We confirmed VV induction of CCL3 expres­
sion in BMDCs (unpublished data).
the course of three consecutive 20­min imaging sessions (the 
first of which is shown in Video 7). To image the inter­
action between OT­I cells and infected macrophages, we   
transferred OT­I cells into mice 12 h before DTx treatment, 
and then infected them with VV­NP­S­eGFP. 6–10 hpi, we 
imaged OT­I cells interacting with VV­infected cells in the 
DLN (Fig. 6 C and Video 8). In both control and DTx­
treated  mice,  OT­I  cells  formed  numerous  tight  contacts 
with infected cells. DTx treatment had no significant effect 
on the mean contact time (27 min in each case during a   
30­min imaging period), arrest coefficients (the fraction of 
time OT­I cells paused on infected cells), or mean T cell 
speeds (Fig. 6, C–H).
Collectively, these data demonstrate that in the absence of 
DCs, OT­I cells migrate into the MRR and form contacts 
with VV­infected macrophages that are grossly indistinguish­
able from their contacts with infected DCs.
CD8+ T cells rapidly scan infected non-DCs
Although T cells can form stable contacts with macrophages 
when DCs are absent, we reasoned that the presence of DCs 
could significantly impact the nature of contacts between   
T cells and macrophages. Therefore, we next used MPM to 
analyze contacts in CD11c­eYFP mice between T cells and 
DCs or macrophages 6 h after VV infection. Over a 20­min 
imaging period, we tracked T cells moving among infected 
(direct­priming) DCs, uninfected DCs (which likely con­
sisted of cross­priming DCs and those expressing amounts of 
fluorescent proteins below detectable levels), and infected 
non­DCs (macrophages; Fig. 7 A). Although there was no 
clear difference in the speed of T cells interacting with in­
fected and uninfected DCs (1.4 µm/min, similar to values 
for  previously  unidentified  infected  cells;  Hickman  et  al., 
2008), T cells interrogated infected non­DCs at a signifi­
cantly higher speed (Fig. 7 B). Likewise, T cells closely scanned 
DCs in a curved path, but moved in straighter lines (indicated 
by  higher  track  linearity)  when  interacting  with  infected 
non­DCs (Fig. 7 C). Finally, we monitored T cell arrest over 
a 30­min period for T cells interacting with each APC cate­
gory (Fig. 7 D). T cells arrested for similar periods over in­
fected and uninfected DCs, but paused for shorter amounts   
of time over non­DCs.
Overall, these data indicate that T cells preferentially form 
stable contacts with DCs (whether overtly infected or not) 
over infected macrophages.
V V induces chemokine production in the DLN
What factors modulate CD8+ T cell interaction with and acti­
vation by DCs? The migration of OT­I cells into the MRR 
in the absence of DCs demonstrates that CD8+ T cells are 
fully capable of entering the MRR, suggesting chemotactic 
recruitment of CD8+ T cells to PIR DCs. Chemokines at­
tract naive CD8+ T cells to antigen­bearing LN DCs in non­
infectious  models  (with  peptide­pulsed  DCs  or  antigen 
targeted to DCs via conjugated Abs; Castellino et al., 2006; 
Hugues et al., 2007). Thus, we performed bioplex analysis for 
Figure 7.  CD8+ T cells rapidly scan infected non-DCs. (A) MPM time 
series of T cells interacting with infected DCs, uninfected DCs, or infected 
non-DCs. CD11c-eYFP mice were given 107 Cell Tracker Blue-labeled  
OT-I cells (blue) and were infected s.c. with V V-NP-S-mCherry 12 h. later. 
Six hpi, inguinal LNs were imaged over sequential 20–30 min periods  
using MPM. The tracks of individual T cells during a 20-min imaging period 
are plotted (right). (B) T cell speeds, (C) track straightness (T cell displace-
ment/track length), and (D) T cell arrest calculated for each type of APC 
interaction over 30 min. Open circles, infected DCs; closed triangles, unin-
fected DCs; closed circles, macrophages. Mean and SEM is shown. Statis-
tics were performed using an unpaired Student’s t test. Shown is one 
experiment of two analyzed with 10–20 nodes per group.JEM Vol. 208, No. 12 
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macrophages  and  DCs  in  the  LN  parenchyma  (Hickman   
et al., 2008). Because viral peptides are generated primarily 
from DRiPs (Dolan et al., 2011), the onset of viral protein 
synthesis is immediately accompanied by the generation of 
class I peptide complexes, which can rapidly initiate CD8+  
T cell priming. For VV, the initial phase of direct priming 
likely persists for 12–24 h (Hickman et al., 2008), after which 
infected DCs and macrophages succumb to viral cytopatho­
genesis or NK­mediated lysis. Because the first 12 hpi are 
critical for activating antiviral T cells after s.c. VV infection 
(Hickman et al., 2008), it is imperative that T cells rapidly 
contact the appropriate infected APC.
The second wave of antigen presentation likely involves 
transfer or acquisition of antigen by LN­resident APCs. 
CD8+ DCs are particularly adept at cross­priming antigens 
acquired from dead or dying cells (den Haan et al., 2000; 
Iyoda et al., 2002). For viruses that infect dermal epithelial 
cells, like herpes simplex virus­1, these cells provide an anti­
gen  source  for  cross­priming  by  migratory  dermal  DCs 
(Bedoui et al., 2009). To date, antiviral cross­priming has 
been investigated largely by ex vivo analyses of cells recov­
ered from dissociated tissues (Allan et al., 2003; Belz et al., 
2004; Bedoui et al., 2009). It will be important in future 
studies to confirm the central role of CD8+ DCs in antiviral 
cross­priming using MPM, although it will be challenging   
to unambiguously identify APCs actively engaged in cross­
priming and not direct priming after synthesis of undetect­
able levels of viral antigens.
The LN CR, a reticular stromal structure at the border of 
the T/B zones, likely serves as a staging ground for both direct 
and cross­priming T cell–APC interactions (Katakai et al., 2004). 
Migratory,  antigen­bearing  DCs  are  thought  to  accumulate   
in the CR, positioning themselves to maximize cross­priming   
interactions with nearby T cells (Bajénoff et al., 2003; Lindquist   
et al., 2004). We show here that direct priming interactions in­
dependent of DC migration also occur in the outermost edges of 
the CR as virions drain to the LN and are captured by resident 
APCs. After the first wave of virus­infected cells die or are elimi­
nated in the LN, it will be interesting to determine the location 
of virus­specific CD8+ T cell–APC interactions in relation to 
the macrophage­rich and dendritic regions of the CR.
Controversy swirls around the definition of macrophages 
versus DCs and their putative differences in priming capacity. 
Chemokine-neutralizing Abs impair the primary CD8+ T cell 
response to V V
Do VV­induced chemokines play an essential role in attract­
ing CD8+ T cells to DCs during viral infection? Remarkably, 
administering a cocktail of neutralizing Abs against CCL3, 
CCL4, and CCL5 dramatically redistributed OT­I cells from 
DCs into the MRR (Fig. 9), which is visualized clearly using 
either two­color (red T cells, green macrophages; Fig. 9 A) 
or three­color MPM (blue CD8+ T cells, green DCs, and red 
macrophages; Fig. 9 C and Video 9). In untreated mice, 
30% of OT­I cells were associated with MRR macro­
phages, but in mice treated with anti­CCL3, ­CCL4, and   
­CCL5  Abs,  >60%  of  OT­I  cells  localized  in  the  MRR   
(Fig. 9 B). s.c. injection of recombinant CCL3 (introducing 
artificial gradients of CCL3 in the uninfected node) also in­
duced T cell scanning of both DCs and the MRR early after 
VV infection (Fig. 9, D and E and Video 10). Additionally, 
CCR5KO OT­I cells failed to form large clusters with   
VV­infected cells at 6 hpi (Fig. 9 F), and many of the cells 
were located in the MRR (visualized using the natural   
autofluorescence of the region; Fig. 9 G and Video 11).
We examined the participation of these chemokines in 
regulating antiviral immune responses via APC selection by   
s.c. injecting a mixture of CCL3­, CCL4­, and CCL5­blocking 
Abs at the time of infection. Chemokine neutralization re­
duced OT­I CD69 induction (an early indicator of activation) 
15 hpi with VV­Ova (Fig. 9 H), and decreased IFN­ synthe­
sis 2 d after infection (Fig. 9 I). In contrast, injection of iso­
type­control Abs did not impact T cell activation (unpublished 
data). In untreated, infected LNs, CCR5KO OT­I cells (lacking 
the CCR5 receptor for these chemokines, but retaining CCR1 
which also signals via several CCR5 ligands) up­regulated 
CD69 to a lesser extent than WT OT­I cells (Fig. 9 J).
Together, these findings demonstrate that the chemokines 
CCL3,  CCL4,  and  CCL5  play  essential  roles  in  enabling   
T cells to reach a complete effector differentiation state and 
maximizing primary antiviral CD8+ T cell responses by enhanc­
ing CD8+ T cell interactions with DCs in the infected node.
DISCUSSION
After s.c. delivery of infectious virions, the most rapid anti­
gen presentation occurs via direct priming. Within seconds, 
lymphatics convey virions to LNs, where they can infect 
Figure 8.  V V infection induces rapid DC chemokine secretion. Mice were infected s.c. with V V-Ova and LN harvested at 6 or 12 hpi Chemokine protein levels 
were determined from clarified node homogenates via Bioplex assay. Dots represent individual mice. Data are shown from two of four independent experiments.2520 Chemokine-dependent APC choice | Hickman et al.
Additionally, LN depletion of CD11c+ cells, which elimi­
nates nearly all DCs and SCS macrophages, has profound   
effects on antiviral priming, despite our direct observations 
that CD8+ T cells now form contacts with macrophages that 
are indistinguishable by IVM from their contacts with DCs 
under nonablative conditions. This argues strongly that DCs 
have a unique role in direct priming that macrophages can­
not replace.
Hume (2008) has eloquently argued that DCs are simply 
mononuclear phagocytes that do not comprise a unique cel­
lular subset, and are not especially adept at priming. A key 
element of Hume’s argument is that the heightened prim­
ing ability of DCs relative to macrophages ex vivo is caused   
by  removing  suppressive  macrophages  during  the  process   
of isolating DCs. Here, we show that in vivo, T cells scan 
DCs  and  macrophages  at  different  rates  in  infected  LNs.   
Figure 9.  Chemokine-based CD8+ T cell homing to DCs. (A) MPM images of animals that were given 1.0 × 107 Cell Tracker Red (red)–labeled OT-I 
cells in the presence or absence (untreated) of chemokine-neutralizing Abs against CCL3, CCL4, and CCL5. Images acquired 6–8 hpi with V V-Ova (non-
fluorescent). MRR delineated by white lines. (B) Percentage of OT-I cells per 63× field (238 × 238 × 85 µm) located in the MRR in untreated or antibody-
treated mice. Results were analyzed with an unpaired Student’s t test. (C) MPM images from the top 30 µm of the inguinal node of CD11c-eYFP mice 
given fluorescent-dextran (red) to label macrophages and OT-I cells (blue). Mice were given chemokine neutralizing Abs; nodes imaged at 8 hpi with non-
fluorescent V V-Ova. (right) A schematic of T cell and macrophage localization after V V infection with CCR5-ligand blockade. Scale bars are shown in  
micrometers. (D and E) OT-I cells (red) in the MRR (green) after s.c. administration of recombinant CCL3 at 2.25 hpi with V V-SIINFEKL (nonfluorescent; E) 
tracks of OT-I cells in the presence (left) or absence (right) of rCCL3 2–3 hpi. Tracks are colored according to mean track speed (slowest [purple) to fastest 
[red]). (F) Distribution of CCR5KO OT-I cells (red, left) or WT OT-I cells (red, right) 6 hpi with V V-NP-S-eGFP (green). (G) CCR5KO OT-I cells (red) in the MRR 
(visualized using the intrinsic autofluorescence of macrophages) at 6 hpi (virus=green, collagen=blue) (H) CD69 expression by LN OT-I cells 15 hpi with 
V V-Ova in the presence or absence of chemokine-neutralizing Abs. Data were averaged from three independent experiments normalized using the high-
est mean fluorescence intensity in an individual experiment as 100. (I) IFN- production by OT-I cells in the node 48 hpi with V V-Ova. Data were com-
piled from two independent experiments and normalized to the highest mean fluorescence intensity per experiment. (J) Same as described in H, but with 
CCR5KO OT-I cells. All experiments were performed at least twice with three to six mice/group.JEM Vol. 208, No. 12 
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MATERIALS AND METHODS
Mice. Specific pathogen–free CD11c­DTR­eGFP transgenic mice on a 
C57BL/6 background were acquired from The Jackson Laboratory (stock # 
4509) and bred in house. Nontransgenic WT controls were C57BL/6 mice. 
CD11c­eYFP  mice  (Lindquist  et  al.,  2004)  were  acquired  through  the   
National Institute for Allergy and Infectious Disease (NIAID) Intramural 
Research Repository and are now available from The Jackson Laboratory 
(stock#  8829).  CCR5KO  mice  (The  Jackson  Laboratory;  stock  #5427) 
were crossed to OT­I TCR transgenic mice (acquired through the NIAID 
Intramural Research Repository) and bred for homozygosity. 6–16­wk­old 
adult mice were used in all experiments. All mice were housed under spe­
cific  pathogen–free  conditions  (including  MNV,  MPV,  and  MHV)  and 
maintained on standard rodent chow and water supplied ad libitum. All ani­
mal procedures were approved by and performed in accordance with the 
NIAID Animal Care and Use Committee.
DC depletion and adoptive transfer. DC depletion was performed as 
described previously (Jung et al., 2002). Mice were given a single of dose of 
DTx at 4 ng/g body weight (Sigma­Aldrich) i.p. in PBS unless another dose 
is noted. CD8+ T cells (TCR transgenic) were transferred 12 h before deple­
tion. Virus infections were always performed 12–24 h after DTx administra­
tion, allowing complete DC depletion before infection. Mice received only 
one dose of DTx.
Dextran and virus injection. Approximately 25 µg of FITC­ or tetra­
methylrhodamine­conjugated 70 kD dextran (Invitrogen) was injected s.c. 
30–45 min before LN analysis where indicated. VV was injected s.c. (3.5 × 107 
PFU) or footpad (104 PFU) in sterile saline. Route of infection is indicated 
for each figure. Previously described VVs used in this study include the fol­
lowing: VV­Ova, VV­NP­S­eGFP, VV­SIINFEKL, VV­Venus­ubiquitin­ 
SIINFEKL, VV­Venus­ubiquitin­NP366­374 (Norbury et al., 2002; Norbury 
et al., 2004; Lev et al., 2008). VV­NP­S­mCherry was constructed accord­
ing to established protocols (Earl et al., 2001).
Adoptive transfers. CD8+ T cells were purified from TCR­transgenic 
rag/  mice  by  negative  selection  using  magnetic­activated  cell  sorting 
(MACS) according to the manufacturer’s instruction (Miltenyi Biotec). Cells 
were 95–99% pure by flow cytometry. Purified cells were labeled with 2 µM 
CFSE (Invitrogen) for 10 min at room temperature in PBS. For IVM, cells 
were labeled with 2 µm CMPTX or CMF2HC (Invitrogen). The amount of 
T cells transferred is indicated in specific figure legends.
Confocal whole-mount microscopy. Whole LNs were removed at in­
dicated time points after infection and placed in 3.2% paraformaldehyde for 
2 h at 4°C. For CD11c­eYFP experiments, mice were given 107 CMF2HC­
labeled (blue) OT­I cells 12 h before infection. Where indicated, mice were 
given lysine­fixable fluorescent dextran s.c. (Invitrogen) 30–45 min before 
removal. Nodes were washed extensively in PBS, and then stained overnight 
with anti­CD11b (clone M1/70; eBioscience) conjugated to Alexa Fluor 
647, or for 2 h with anti­F4/80 (clone BM8; eBioscience). Nodes were 
washed in PBS before slicing into smaller pieces, which were mounted on 
slides in Fluoromount G (Electron Microscopy Sciences). Slides were im­
aged on an SP5 confocal microscope (Leica).
Ex vivo analyses of dissociated LNs. For flow cytometric determination 
of the nature and number of infected cells per node, untreated or CD11c­DTR­
eGFP mice treated with DTx were given 3.5 × 107 PFU VV­NP­S­mCherry 
8–12 h before removal of inguinal LNs. Single­cell suspensions were gener­
ated via digestion in collagenase (Worthington Biochemical Corporation) + 
dispase (Roche) before staining for CD11c, CD11b, CD169, F4/80, and 
GR­1. Cells were gated on mCherry+ vaccinia­infected cells before addi­
tional analyses of individual cell populations.
For determination of the nature and number of dextran+ cells, mice 
were given 0.25 µg FITC­conjugated 70 kD dextran 30–45 min before node 
removal and digestion with collagenase + dispase. Single­cell suspensions 
What is the role for the large numbers of infected LN 
macrophages if not for priming naive CD8+ T cells? Re­
cently, Asano et al. (2011) showed that these macrophages 
serve as facile APCs via cross­presentation of tumor associated 
antigens, making their failure to drive antiviral T cell responses 
even  more  enigmatic.  Several  imaging  studies  have  now 
shown antigen acquisition by SCS sinus macrophages and 
subsequent  antigen  donation  to  LN  B  cells  (Batista  and   
Harwood, 2009). Perhaps virally infected nodal macrophages 
specialize in presentation to B cells and are largely ignored by 
T cells (much like CD8+ DCs preferentially present to CD8+ 
and not CD4+ T cells; Dudziak et al., 2007). Additionally, 
these macrophages express the molecule sialoadhesin, a newly 
identified participant in regulatory T cell function and expan­
sion, raising the possibility that macrophage infection activates 
suppressive rather than effector T cells (Wu et al., 2009).
We show that macrophages prime CD8+ T cells that are 
sub­optimally activated by the standard criteria. It remains to 
be determined, however, whether there is method to this 
madness and the “partially” activated cells are fully activated 
for a specific alternative function in primary or memory re­
sponses. Alternatively, macrophages may serve to dampen 
initial CD8+ T cell responses generated via direct priming, 
favoring instead cross­priming at later time points. In any 
event, it is a safe assumption that macrophages perform mul­
tiple functions in the infected LNs.
In clearly demonstrating the essential role DCs play in di­
rect antiviral priming, our findings emphasize the importance 
of understanding the basis for CD8+ T cell attraction to in­
fected PIR DCs. This knowledge is likely to be useful in maxi­
mizing the ability of vaccines to elicit effective CD8+ T cell 
responses. We provide the initial evidence that CCR5 and R1­
signaling chemokines, known to guide CD8+ T cells to cross­
priming DCs in noninfectious models (Castellino et al., 2006; 
Hugues et al., 2007), also play a critical role in direct priming 
during viral infection. We show, first, that viruses rapidly in­
duce chemokines in the LN, and second, that an Ab cocktail 
that neutralizes several of the known CCR5 ligands inhibits 
both DC attraction of CD8+ T cells and CD8+ T cell IFN­ 
responses. Additionally, these experiments likely underestimate 
the importance of CCR5 agonist chemokines in direct anti­
viral CD8+ T cell priming, since it is unlikely that the Ab cock­
tail we used covers all CCR5 agonists or completely neutralizes 
the agonists covered. Likewise, experiments using CCR5KO 
OT­I cells will similarly undervalue the effect of these che­
mokines on CD8+ T cell responses as the cells retain signaling 
through CCR1–CCL3 and –CCL5 interactions.
Because of its relevance for rational vaccine design, there 
is tremendous interest in identifying APC types that most   
effectively prime functional CD8+ T cell responses. We have 
identified a factor that optimizes CD8+ T cell targeting to 
appropriate APCs during viral infection. This raises the excit­
ing possibility of engineering vaccines to express optimal an­
tigens as well as a guidance system to attract CD8+ T cells to 
DCs for maximal priming of effector cells with optimal effec­
tor profiles.2522 Chemokine-dependent APC choice | Hickman et al.
Bioplex  assay.  LN  chemokines  were  analyzed  during  infection  using   
a bead­based assay (Bioplex; Bio­Rad Laboratories) and results were read   
out on a Bioplex Suspension Array System (Bio­Rad Laboratories). Experi­
ments were basically performed according to the manufacturer’s instruc­
tions. To gain more reproducible virus drainage to the LN, we analyzed 
cytokines  within  the  popliteal  LN  instead  of  the  inguinal.  Mice  were   
infected for various time points with VV­NP­S­eGFP (104 PFU footpad), 
and the skin­draining popliteal LN was removed and placed 250 µl buffered 
saline solution with 0.1% BSA. Two nodes were pooled for a single sam­
ple.  LNs  were  homogenized  in  solution,  and  samples  were  centrifuged   
at 14,000 g for 6 min to remove cellular debris. Exactly 100 µl of clarified 
supernatant  was  used  per  sample,  and  samples  performed  in  duplicate.   
Results were analyzed using GraphPad Prism Software Version 5.0 (Graph­
Pad).  Error  bars  represent  SEM,  and  groups  compared  using  unpaired   
Student’s t tests.
Kb-SIINFEKL  complex  staining.  CD11c­DTR­eGFP  mice  received   
4 ng/g DTx i.p. or PBS i.p. 12 h before s.c. infection with VV­Venus­ubiquitin­ 
SIINFEKL or VV­Venus­Ub­NP366­374. 6 hpi with VV, draining inguinal 
LNs were removed and digested with collagenase type II (Worthington Bio­
chemical Corporation). Single­cell suspensions were stained with 25D­1.16­
Alexa Fluor 647 (produced in­house but comparable product available from 
eBioscience) and propidium iodide and analyzed on a LSRII flow cytometer 
(BD). Plots were gated on live cells and Venus (eYFP)+ cells before analysis 
of 25D­1.16 staining.
Chemokine-neutralizing Abs and recombinant chemokine injec-
tion. 50 µg each of anti­CCL3 (MAB450), anti­CCL4 (MAB451), and anti­
CCL5 (MAB478; all from RND Systems) were given i.v. in sterile saline at 
the same time as infection. Alternatively, 150 µg rat IgG2a (BioXcell) was 
given in the same manner. 1 µg of rCCL3 (R&D Systems) in sterile saline 
was given s.c. 45 min to 1 h before imaging.
CFSE proliferation. Spleens, inguinal, brachial, cervical, and mesenteric 
LNs were removed and homogenized to produce single­cell suspensions. 
Red blood cells were lysed, and samples were filtered through a 70­µm nylon 
filter. Cells were labeled for 10 min at room temperature in 2 µM CFSE   
(Invitrogen). 5 × 106 OT­I cells were transferred i.v. into CD11c­DTR­eGFP 
mice, which were treated with DTx or PBS i.p. 12 h later, mice were infected 
s.c. with 3.5 × 107 PFU VV­NP­S­eGFP. 48 hpi, inguinal nodes were re­
moved and analyzed by flow cytometry. OT­I cells were stained for CD45.1 
(clone A20) and CD8 (clone 53–6.7) from eBioscience as well as propidium 
iodide, and analyzed for CFSE fluorescence on a BD LSRII flow cytometer 
(BD). Proliferation was then examined using FlowJo (Tree Star).
OT-I cellular activation assays. 12 h before infection s.c. with 3.5 × 107 
PFU VV­ovalbumin, 5 × 106 OT­I cells were transferred i.v. into WT mice. 
For activation marker analysis, OT­I cells were removed from the draining 
ILN at indicated time points after infection using homogenization. Red 
bloods cells were lysed, and samples were filtered through a 70 µm nylon fil­
ter. Single­cell suspensions were stained for CD69 (clone H1.2F3), CD25 
(clone  PC61),  CD62L  (clone  Mel­14),  CD45.1  (clone  A20),  and  CD8 
(clone 53–6.7; eBioscience). Results were compiled from four independent 
experiments  by  normalizing  the  maximum  CD69  MFI  per  experiment   
to 100. Where indicated, mice received a single injection of chemokine­
neutralizing Abs at the same time as infection.
For analysis of IFN­ production, WT or CD11c­DTR­eGFP mice 
(indicated in figure legends) were infected s.c. with 2.5 × 107 PFU VV­ 
ovalbumin or VV­NP­S­eGFP. Where indicated, mice received a single in­
jection of chemokine­neutralizing Abs i.v. concomitant with infection. Inguinal 
LNs were harvested 48 hpi and homogenized, and cells were resuspended in 
RPMI­10 + 10 mM Hepes buffer and plated at 2 × 106 cells/well in U­bottom, 
96­well plates along with SIINFEKL or an irrelevant control peptide (SSIE­
FARL) at a final concentration of 100 nM. Cells and peptide were incubated 
for 3 h. at 37°C in the presence of 10 µg/ml brefeldin A (Sigma­Aldrich) to 
were stained for CD11c, CD11b, F4/80, and GR­1. Cells were gated on the 
FITC+ population before analyzing individual cell types.
Histochemistry on frozen LN sections. LNs were removed and embed­
ded in OCT medium (Electron Microscopy Sciences) and frozen in dry­ice 
cooled isopentane. 20 µm sections were cut on a Leica cryostat (Leica). Sec­
tions were fixed in ice cold­acetone for 5 min before blocking with 5% goat 
or donkey serum, then staining with the following Abs: ER­TR7 (clone 
ER­TR7;  Abcam),  CD11b  (clone  M1/70;  eBioscience),  F4/80  (clone 
BM8; eBioscience), CD11c (clone N418; eBioscience), B220 (clone RA3­
6B2; eBioscience), pNAd (clone Meca­79; BD), CD8 (clone 53–6.7; eBio­
science), and GR­1 (clone RB6­8C5; eBioscience).
MPM. CD8+ T cells labeled with CFSE, CMTPX (C42H40ClN3O4), or 
CMF2HC (4­chloromethyl­6,8­difluoro­7­hydroxycoumarin; all from In­
vitrogen) were injected intravenously 12–24 h before injection with virus, 
unless otherwise specified. When indicated, mice were given 25 µg FITC­ 
or rhodamine­conjugated 70­kD dextran (Invitrogen) s.c. for drainage to the 
inguinal LN. Two­photon imaging used an inverted TCS­SP2 MP confocal 
microscope (Leica) equipped with a 20× objective (numerical aperture, 0.7) 
or 63× objective (numerical aperture, 1.30) and with 80% glycerol as the 
immersion medium for each objective. Two­photon excitation was pro­
vided by a Mai Tai Ti:Sapphire laser (Spectra Physics) with a 10­Watt pump, 
tuned to 800 nm for imaging of cells labeled with CMTPX, FITC, or 
CMF2HC; 850 nm for imaging of cells labeled with CMTPX in combina­
tion with eGFP; or 900 nm for imaging of eGFP alone or for imaging of 
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two­channel nondescanned detector. Wavelength separation was accom­
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525/50 nm bandpass and 610/75 nm bandpass. For imaging of cellular inter­
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cells, and the other was set at 900–930 nm for imaging VV­NP­S­mCherry 
and eYFP. Images were obtained in sequential mode using the same 63× 
objective as in the previous paragraph. Sections were taken at 2.5­µm inter­
vals for a total depth of 40 µm. Series were acquired every minute.
Data analyses. Data were analyzed with Imaris 64 version 6.1.2 (Bit­
plane). Images were processed using the Gaussian filter algorithm. Con­
tact  times  between VV­infected  cells  and  OT­I  cells  were  calculated 
manually  and  compiled  from  3–5  separate  movies  for  each  condition 
(DTx­treated or WT). Contacts were defined as being in close proximity 
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were calculated using the Imaris XT function “plot length of selected 
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image were plotted using GraphPad Prism 5. Overlays of tracks were gen­
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MRR was calculated by determining the number of OT­I cells associated 
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compiled. Results were analyzed using GraphPad Prism 5 software. Means 
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